FDA approvals of these biosimilars started in 2016, but only 1 such product has successfully launched.
Lisa Cristofaro, PharmD, BS, BCACP
Advertisement
Articles by Lisa Cristofaro, PharmD, BS, BCACP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
2
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
3
Earlier Menopause, Reduced Cardiac Function Potentially Linked With Negative Impacts on Brain Health
4
Menopause Care Varies by Provider, Highlighting Need for Standardized Education
5
